Brandon Coyle is a Director of Pivotal Purification Process Development at Gilead Sciences, leading the bioconjugation process for Antibody Drug Conjugates (ADCs). Previously, they held multiple roles at Gilead, including Associate Director and Senior Research Scientist I, and served as a Downstream Engineer at Avitide, Inc. Brandon's early career included a position as a TSA+ Process Development Engineer at Hutchinson Technology Inc. and a Doctoral Researcher at the University of Washington, where they pioneered innovative protein purification technologies. Brandon earned a degree in Chemical Engineering from the South Dakota School of Mines and Technology with a 3.95 GPA.
This person is not in the org chart
This person is not in any teams
This person is not in any offices